
==== Front
Naunyn Schmiedebergs Arch Pharmacol
Naunyn Schmiedebergs Arch Pharmacol
Naunyn-Schmiedeberg's Archives of Pharmacology
0028-1298
1432-1912
Springer Berlin Heidelberg Berlin/Heidelberg

38112730
2904
10.1007/s00210-023-02904-9
Research
Enhancement of cardiac angiogenesis in a myocardial infarction rat model using selenium alone and in combination with PTXF: the role of Akt/HIF-1α signaling pathway
Elseweidy Mohamed M. mmElseweidy@pharmacy.zu.edu.eg

1
Ali Sousou I. 1
Shaheen Mohamed A. 2
Abdelghafour Asmaa M. 1
Hammad Sally K. 1
1 https://ror.org/053g6we49 grid.31451.32 0000 0001 2158 2757 Biochemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519 Egypt
2 https://ror.org/053g6we49 grid.31451.32 0000 0001 2158 2757 Histology and Cell Biology Department, Faculty of Human Medicine, Zagazig University, Zagazig, 44519 Egypt
19 12 2023
19 12 2023
2024
397 7 46774692
30 10 2023
11 12 2023
© The Author(s) 2023
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Ischemic heart diseases such as myocardial infarction (MI) are a global health problem and a leading cause of mortality worldwide. Angiogenesis is an important approach for myocardial healing following ischemia. Thus, this study aimed to explore the potential cardiac angiogenic effects of selenium (Se), alone and in combination with the tumor necrosis factor-alpha inhibitor, pentoxifylline (PTXF), via Akt/HIF-1α signaling. MI was induced in rats using two subcutaneous doses of isoprenaline (ISP) at a 24-h interval (150 mg/kg). One week later, rats were orally given Se (150 µg/kg/day), PTXF (50 mg/kg/day), or Se/PTXF combination. ISP-induced myocardial damage was evident by increased HW/TL ratios, ST segment elevation, and increased serum levels of CK-MB, LDH, and troponin-I. ISP increased the cardiac levels of the lipid peroxidation marker MDA; the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α; and the pro-apoptotic protein Bax and caspase-3. In contrast, the cardiac levels of the antioxidant markers GSH and SOD and the anti-apoptotic marker Bcl-2 were reduced. Furthermore, ISP markedly increased the cardiac levels of p-Akt and HIF-1α proteins and the cardiac gene expression of ANGPT-1, VEGF, and FGF-2. Treatment with Se both alone and in combination with PTXF ameliorated the ISP-induced myocardial damage and further increased cardiac angiogenesis via Akt/HIF-1α signaling. Se/PTXF combined therapy was more beneficial than individual treatments. Our study revealed for the first time the cardiac angiogenic effects of Se both alone and in combination with PTXF in myocardial infarction, suggesting that both may be promising candidates for clinical studies.

Graphical Abstract

Keywords

Myocardial infarction
Angiogenesis
Akt
HIF-1α
Selenium
Pentoxifylline
Zagazig UniversityOpen access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

issue-copyright-statement© Springer-Verlag GmbH Germany, part of Springer Nature 2024
==== Body
pmcIntroduction

Vascular health and good oxygen supply are essential to maintain normal tissue and organ function and to avoid the overwhelming consequences caused by inadequate blood flow (Johnson et al. 2019). Ischemic heart diseases including myocardial infarction (MI) are considered a major global health problem and a leading worldwide cause of mortality (Nowbar et al. 2019). Management of MI can be done either surgically to restore blood supply instantly or by using pharmacotherapy to stabilize the disease and reduce its acute complications. However, not all MI patients are eligible for these interventions (Johnson et al. 2019). Therefore, new strategies for MI management are strongly needed.

Myocardial healing following MI includes a strong angiogenic response which extends into the infarct core resulting in favorable results such as reduced infarct scars, improved cardiac function, and less remodeling (Wu et al. 2021). Angiogenesis is an essential physiological and pathophysiological process that plays a significant role in fetal development, reproduction, healing of wounds in addition to cancer growth and progression (Johnson et al. 2019). It is described as the sprouting of new capillaries from preexisting vasculature through endothelial cells stimulation, migration, and proliferation (Tomanek and Schatteman 2000). Angiogenesis is triggered by hypoxia as an adaptive response to diminished oxygen supply. It is regulated via several angiogenic growth factors including angiopoietins (ANGPT), fibroblast growth factors (FGF), and vascular endothelial growth factors (VEGF) (Wu et al. 2021). These growth factors are regulated by protein kinase-B (Akt) and hypoxia inducible factor-1 alpha (HIF-1α) signaling pathways that are activated by hypoxia (Zhang et al. 2018).

Selenium (Se) is an essential trace element which exists in many food sources in various chemical forms including the organic selenocompounds such as selenomethionine and selenocysteine in addition to the inorganic forms including sodium selenite and selenious acid. Selenium bioavailability and pharmacokinetics rely on the form of the administered selenocompound (Benstoem et al. 2015; Al-Mubarak et al. 2021). Selenium is essential for various body functions including antioxidant and immune systems, cardiovascular function, thyroid hormone synthesis, and cancer prevention. Balanced levels of Se are crucial for optimal biological functions where deleterious effects can be caused by very low or very high selenium consumption (Benstoem et al. 2015). Selenium deficiency is greatly related to several cardiovascular diseases such as heart failure and myocardial infarction (Tapiero et al. 2003; Mangiapane et al. 2014). It has a wide range of biological activities including antioxidant, anti-apoptotic, and anti-inflammatory effects which explains its ability to offer protection against cellular damage and death (Shalihat et al. 2021). Moreover, Vural et al. reported that Se administration increased plasma levels of VEGF in diabetic rats suggesting that it may have angiogenic effects (Vural et al. 2017).

Pentoxifylline (PTXF) is a xanthine derivative that has several biological activities such as anti-inflammatory and antioxidant effects, in addition to improving the blood rheological properties (Wen et al. 2017). In a rat model of ischemia/reperfusion, Matboli et al. showed that PTXF administration resulted in enhancements in cardiac structure and function (Matboli et al. 2020). Moreover, Dhulqarnain et al. showed that PTXF activated Akt signaling resulting in spermatogenic cell survival in a mouse model of testicular torsion-detorsion (Dhulqarnain et al. 2021). Additionally, in a rat model of obstructive nephropathy, Zhou et al. reported that PTXF ameliorated tubulointerstitial fibrosis via upregulation of VEGF expression (Zhou et al. 2009). PTXF also increased gastric VEGF concentration resulting in healing of gastric ulcers in diabetic rats (Baraka et al. 2010).

To the best of our knowledge, no previous studies have investigated the cardiac angiogenic effects of Se either alone or in combination with PTXF or explored the mechanism by which they exert their angiogenic effects, in a rat model of MI. Additionally, no previous studies have examined the effects of combining selenium and pentoxifylline in MI management. Therefore, the current study aimed to (i) investigate the potential effects of Se and PTXF in MI management, (ii) explore the molecular mechanisms by which Se and PTXF may ameliorate cardiac injury induced in rats, and (iii) examine whether Se + PTXF combination might provide extra benefits.

Materials and methods

Animals

Thirty male Wistar rats (190 ± 10 g) were bought from the Faculty of Veterinary Medicine (Zagazig University, Zagazig, Egypt). Rats were kept under controlled environmental conditions: 25 ± 2 °C room temperature and a 12-h light/12-h dark cycle. Rats had access to a standard diet and water ad libitum. After 1 week of acclimatization, rats were randomly allocated into one of five groups (n = 6 each). National Institutes of Health (NIH) guidelines for the handling of laboratory animals were followed during the design of experimental protocol and procedures. Experimental protocol was approved by the Institutional Animal Care and Use Committee, Zagazig University (ZU-IACUC): approval number ZU IACUC/3/F/168/2021.

Experimental groups

Six rats were allocated into the normal control group (NG). Myocardial infarction was induced in rats using ISP (Acros Organics™, New Jersey, USA). ISP was injected SC at 150 mg/kg, twice over a 24-h interval (Ahmed et al. 2020; Pawar et al. 2022). The effectiveness of MI induction was confirmed in rats by the assay of cardiac injury markers including CK-MB, LDH, and troponin-I, 48 h after the first ISP injection. In addition, ECG analysis was carried out. Significant increases in CK-MB, LDH, and troponin-I levels, in addition to ST segment elevation, were seen in all the rats used in this study. One week later, rats were distributed into four groups (n = 6 each) (Fig. 1):ISP group: rats received 1 ml of vehicle orally for 6 weeks.

Se group: rats were treated orally with Se as Na2SeO3 (Sigma-Aldrich, Missouri, USA) at 150 µg/kg/day) (Dallak 2017) for 6 weeks.

PTXF group: rats were treated orally with PTXF (Trental®, Sanofi Aventis, Germany) at 50 mg/kg/day) (Garcia et al. 2015) for 6 weeks.

Se + PTXF group: rats were treated orally with Se and PTXF, in the doses mentioned above.

Fig. 1 A schematic illustration of the experimental design

Electrocardiography (ECG) monitoring

ECG was recorded twice: 48 h after the first ISP injection and at the end of the experimental period (Youssef et al. 2021; Ahmad et al. 2022; Ghazouani et al. 2022). Rats were anesthetized thiopental sodium (60 mg/kg, IP) (Jafarinezhad et al. 2019); then, they were kept in a supine position with electrodes subcutaneously inserted in their paws. An ECG PowerLab module and a Bio-Amplifier (AD Instruments, Australia) were used for ECG monitoring. Data analysis was conducted using LabChart 7 software.

Sampling

At the end of the study (7 weeks after the first ISP injection), blood samples were collected and sera were separated and kept at − 20 °C, for further biochemical assays. Cervical dislocation was used to euthanize the rats. To verify death prior to tissue collection, respiratory arrest was checked and confirmed. In addition, it was verified, by palpation, that there is no heartbeat. Then, the hearts were isolated, rinsed with saline, dried, and weighed. Part of each left ventricle (LV) was stored at − 80 °C for use in further assays. The other part was fixed in 4% formaldehyde and then processed for histological and immunohistochemical studies.

Biochemical analyses

In serum

Serum levels of creatine kinase-MB (CK-MB) and troponin-I were determined using rat ELISA kits purchased from BioVision, Inc. (California, USA). Serum lactate dehydrogenase (LDH) was measured using rat ELISA Kits obtained from Lifespan Bioscience, Inc. (Washington, USA). The analysis was done according to the manufacturers’ instructions.

In cardiac tissue

Cardiac levels of glutathione (GSH), malondialdehyde (MDA), and superoxide dismutase (SOD) activity were assessed using kits obtained from BioVision, Inc. (California, USA). Moreover, cardiac levels of tumor necrosis factor-alpha (TNF-α) were determined using a BioLegend® rat ELISA kit (California, USA). The cardiac levels of interleukin-6 (IL-6) and interleukin-1β (IL-1β) were evaluated using rat ELISA kits provided from Cloud-Clone Crop® (Texas, USA).

The cardiac levels of Bax and Bcl-2 were measured using rat ELISA kits supplied from Cloud-Clone Crop® (Texas, USA), while cardiac caspase-3 levels were determined using rat ELISA kits supplied from BioVision, Inc. (California, USA). All assays were conducted according to the manufacturer’s instructions.

Western blot analysis

Total protein extraction from cardiac tissues was done using the ReadyPrep™ protein extraction kit (Bio-Rad Inc., California, USA) in accordance with manufacturer’s instructions. TGX Stain-Free™ FastCast™ Acrylamide kit (Bio-Rad Inc., California, USA) was used to resolve protein samples. This was followed by the transfer of resolved protein samples into PVDF membranes and blocking using 3% bovine serum albumin, at room temperature for 1 h. Afterwards, membrane incubation with primary antibodies for p-Akt, t-Akt, and HIF-1α, (Santa Cruz Biotechnology, Inc., Europe) was performed overnight, at 4 °C. Then, incubation with the secondary antibody was done for 1 h, at room temperature. Target proteins bands were visualized using the enhanced chemiluminescence system, Clarity™ Western ECL substrate (Bio-Rad Inc., USA). Target proteins expression was quantified relative to that of β-actin (Little et al. 2017; Younis et al. 2021a, b).

Quantitative real-time PCR

A Direct-zol RNA Miniprep Plus kit (Zymo Research Corp., USA) was used for total RNA isolation from cardiac tissues. Reverse transcription of isolated RNA into complementary DNA and amplification were done using SuperScript™ III Platinum™ SYBR™ Green One-Step qPCR Kit w/ROX (Invitrogen, USA) and a StepOne™ PCR system (Applied Biosystem, USA). mRNA relative expression was determined using GAPDH gene as an internal control and the 2−ΔΔct method.

The sequences of primers utilized for PCR were as follows:TNF-α Forward primer (5′-TGCCTCAGCCTCTTCTCATT-3′) and Reverse primer (5′-GAGCCCATTTGGGAACTTCT-3′)

IL-6 Forward primer (5′-AGTTGCCTTCTTGGGACTGA-3′) and Reverse primer (5′-CCTCCGACTTGTGAAGTGGT-3′)

IL-1β Forward primer (5′-GAAGTCAAGACCAAAGTGG-3′) and Reverse primer (5′-TGAAGTCAACTATGTCCCG-3′)

BAX Forward primer (5′-TTTCATCCAGGATCGAGCAG-3′) and Reverse primer (5′-AATCATCCTCTGCAGCTCCA-3′)

Bcl-2 Forward primer (5′-GACTTTGCAGAGATGTCCAG-3′) and Reverse primer (5′-TCAGGTACTCAGTCATCCAC-3′)

Caspase-3 Forward primer (5′-CGATTATGCAGCAGCCTCAA-3′) and Reverse primer (5′-AGGAGATGCCACCTCTCCTT-3′)

VEGF Forward primer (5’-GCCGTCCTGTGTGCCCCTAATG-3’) and Reverse primer (5’-GTTCTATCTTTCTTTGGTCTGC-3’)

FGF-2 Forward primer (5′-GAAGGAAGATGGACGGCTGC-3′) and Reverse primer (5′-TGACAGTGTCTAAAGAGAGTC-3′)

ANGPT-1 Forward primer (5′-CAGTCAGAGGCAGTACATGC-3′) and Reverse primer (5′-GCATAAGGGCGCATTTGCAC-3′)

GAPDH Forward primer (5′-CCTCGTCTCATAGACAAGATGGT-3′) and Reverse primer (5′-GGGTAGAGTCATACTGGAACATG -3′)

TNF-α is tumor necrosis factor-alpha, IL-6 is interleukin-6, IL-1β is interleukin-1β, Bax is Bcl-2-associated X, Bcl-2 is B cell lymphoma 2, VEGF is vascular endothelial growth factor, FGF-2 is fibroblast growth factor-2, ANGPT-1 is angiopoietin-1, and GAPDH is glyceraldehyde 3-phosphate dehydrogenase.

Histological study

Heart samples were fixed in 4% formaldehyde. After fixation, the samples were dehydrated in ascending grades of alcohol, cleared in xylene, and embedded in paraffin. Five-micrometer paraffin sections were cut using a microtome, deparaffinized, and rehydrated. Sections were then processed for staining with hematoxylin and eosin (H&E) and Masson’s trichrome stain (Suvarna et al. 2018; Hammad et al. 2021). A light microscope was used to examine the stained sections (Olympus BX40). Images of three to five random non-overlapping fields were captured per slide. To assess the myofiber diameter, H&E-stained sections were examined at a magnification of 400 × (Younis et al. 2021c; Mohamed et al. 2023). Masson’s trichrome stain was used to quantify the percentage of fibrosis and the stained sections were examined at a magnification of 200 × . Interstitial collagen deposition was indicated by the blue-stained areas. To quantify the percentage of fibrosis and the myofiber diameter and, the captured images were analyzed using ImageJ 1.53k software (NIH, Maryland, USA) (Younis et al. 2021a, b, c; Elseweidy et al. 2023; Mohamed et al. 2023).

Immunohistochemical study

Deparaffinization of heart sections was carried out followed by rehydration with ethanol and incubation with hydrogen peroxide (3%) for 15 min. The slides were then heated in 10 mM sodium citrate buffer, pH 6 for 10 min to achieve antigen retrieval. Afterwards, the slides were kept at room temperature for 20 min, washed in PBS, and incubated with CD31 primary antibody (Abcam, Cambridge, UK), at 4 °C overnight. After washing the slides with PBS, incubation with a horse radish peroxidase–conjugated secondary antibody at room temperature was carried out. The chromogen 3,3′-diaminobenzidine (Sigma Aldrich, USA) was used after washing the slides in PBS. The CD31-stained heart sections were then evaluated for the extent of positive staining by light microscopy at a magnification of 200 × , where the brown color indicated positive staining for CD31 (Yan et al. 2021). CD31-positive staining was analyzed using ImageJ software (NIH, Maryland, USA) (Broeke et al. 2015).

Statistical analysis

All statistical analysis was performed using GraphPad Prism software. Data were expressed as mean ± SD and the statistical difference between groups was assessed using one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test. Statistical significance was set at p < 0.05.

Results

Cardiac injury markers and cardiac hypertrophy

Cardiac injury was assessed by the reliable diagnostic markers, troponin-I, CK-MB, and LDH, while heart weight to tibia length (HW/TL) ratios were used to evaluate cardiac hypertrophy. ISP significantly increased (HW/TL) ratios along with the serum levels of troponin-I, CK-MB, and LDH, compared to normal group (p < 0.001). Rats treated with Se, PTXF, or their combination (Se + PTXF) had markedly lower HW/TL ratios and serum levels of troponin-I, CK-MB, and LDH compared to rats in the ISP group (P < 0.001). The combined group (Se + PTXF) showed a better outcome than monotherapy (p < 0.01) (Table 1). Table 1 Cardiac injury markers and cardiac hypertrophy in rats with MI induced by ISP and treated with selenium, pentoxifylline, or their combination

Groups	HW/TL	Serum troponin-I	Serum CK-MB	Serum LDH	
	(mg/mm)	(pg/ml)	(pg/ml)	(ng/ml)	
NG	6.66 ± 0.6	29.5 ± 4.8	36.5 ± 6.2	3.5 ± 0.8	
ISP	16.73 ± 2.6*	134.5 ± 6.8*	295.5 ± 25.9*	25.2 ± 3.5*	
Se	10.15 ± 0.5#	60.6 ± 4.1#	92.4 ± 16.5#	14.5 ± 1.7#	
PTXF	10.9 ± 0.4#	62.6 ± 4.5#	109.1 ± 13.9#	14.9 ± 1.9#	
Se + PTXF	7.9 ± 0.2#ab	39.9 ± 3.2#ab	48.9 ± 5.2# ab	4.7 ± 0.7# ab	
MI was induced in rats with isoprenaline (ISP). Rats were treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). Results are expressed as mean ± SD, n = 6

*Significant difference versus NG group at p < 0.001

#significant difference versus ISP group at p < 0.001

asignificant difference versus Se group at p < 0.01

bsignificant difference versus PTXF group at p < 0.01

ECG changes

One of the most important characteristics of MI on an ECG is ST segment elevation. ISP induced a marked increase in ST segment elevation compared to the NG rats (p < 0.001). This abnormality was ameliorated upon treatment with Se, PTXF, or Se/PTXF combination (p < 0.001). The Se/PTXF combined group was superior to either monotherapy in ameliorating ECG changes (p < 0.01) (Fig. 2).Fig. 2 ECG changes in rats with MI induced by isoprenaline (ISP) and treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). A ECG graph. B ST segment elevation. Results are expressed as mean ± SD (n = 6). ST-segment elevation (orange arrow)

Cardiac oxidative stress

Oxidative stress correlates with increased incidence of cardiac events such as MI (Grieve et al. 2004). Therefore, we assessed the cardiac levels of MDA, GSH, and SOD. ISP induced a significant increase in cardiac MDA levels with a significant decrease in the cardiac levels of the antioxidant markers GSH and SOD compared to the NG group (p < 0.001). These effects were significantly improved upon treatment with Se, PTXF, or Se/PTXF combination (p < 0.001). Se/PTXF combination was more effective in ameliorating cardiac oxidative stress than monotherapy (p < 0.001) (Fig. 3).Fig. 3 Cardiac oxidative stress in rats with MI induced by isoprenaline (ISP) and treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). Cardiac content of A MDA, B GSH, and C SOD. Results are expressed as mean ± SD, n = 6

Cardiac inflammation

Mounting literature had established the relationship between MI and inflammation (Deten et al. 2002; Debrunner et al. 2008). We assessed the cardiac mRNA expression as well as the cardiac protein levels of the pro-inflammatory cytokines; TNF-α, IL-6, and IL-1β. Figure 4 and Table 2 show that ISP rats had a marked increase in the cardiac mRNA expression as well as the cardiac protein levels of TNF-α, IL-6, and IL-1β, compared to the NG rats (p < 0.001). Treatment with Se, PTXF, or Se/PTXF combination significantly reduced them, compared to ISP rats (p < 0.001). A more significant reduction was observed in the Se/PTXF combined group compared to individual treatments (p < 0.01).Fig. 4 Cardiac inflammation in rats with MI induced by isoprenaline (ISP) and treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). Relative cardiac mRNA expression of A TNF-α, B IL-6, and C IL-1β. Results are expressed as mean ± SD, n = 6

Table 2 Cardiac inflammation in rats with MI induced by ISP and treated with Selenium, pentoxifylline or their combination

Groups	Cardiac TNF-α	Cardiac IL-6	Serum IL-1β	
	(pg/mg protein)	
NG	44.07 ± 5.6	34.5 ± 9.2	31.1 ± 2.6	
ISP	215 ± 13.7*	132.7 ± 21.6*	191.6 ± 16.4*	
Se	153.1 ± 7.4#	72.4 ± 4.2#	133.7 ± 6.7#	
PTXF	148.7 ± 9.6#	67.7 ± 5.4#	129 ± 9.3#	
Se + PTXF	53.5 ± 8.3#ab	38.7 ± 1.7# ab	56.6 ± 6.1# ab	
MI was induced in rats with isoprenaline (ISP). Rats were treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). Results are expressed as mean ± SD, n = 6

*Significant difference versus NG group at p < 0.001

#significant difference versus ISP group at p < 0.001

asignificant difference versus Se group at p < 0.01

bsignificant difference versus PTXF group at p < 0.01

Cardiac apoptosis

Apoptosis is a key pathological characteristic of MI, which leads to both structural and functional abnormalities (Abbate et al. 2006). ISP induced a marked increase in the cardiac mRNA expression as well as the cardiac protein levels of BAX and caspase-3 and a significant reduction in the cardiac mRNA expression as well as the cardiac protein levels of Bcl-2, compared to the NG (p < 0.001). These effects were markedly improved upon treatment with Se, PTXF, or Se/PTXF combination (p < 0.001). Se/PTXF combination was more effective in ameliorating cardiac apoptosis induced by ISP than monotherapy (p < 0.01) (Fig. 5).Fig. 5 Cardiac apoptosis in rats with MI induced by isoprenaline (ISP) and treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). Relative cardiac mRNA expression of A BAX, B Bcl-2, and C caspase-3. Cardiac protein levels of D BAX, E Bcl-2, and F caspase-3. Results are expressed as mean ± SD, n = 6

Cardiac Akt/HIF-1α signaling

Akt/HIF-1α signaling plays an important role in cardiac healing following ischemia as it regulates various cellular processes related to cell survival and angiogenesis (Zhang et al. 2018). Rats in the ISP group had significantly higher ratios of p-Akt/t-Akt and HIF-1α protein levels than NG rats (p < 0.001 and p < 0.01, respectively). Treatment with Se, PTXF, or their combination further increased cardiac p-Akt/t-Akt ratios and HIF-1α protein levels, compared to the ISP group with the best outcome seen in the Se/PTXF group (Fig. 6).Fig. 6 Cardiac Akt/HIF-1α signaling in rats with MI induced by isoprenaline (ISP) and treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). A Representative Western blots of p-Akt, t-Akt, HIF-1α, and β-actin, B cardiac p-Akt/t-Akt ratios. C Relative expression of cardiac HIF-1α protein. Results are expressed as mean ± SD

Cardiac expression of angiogenesis genes

Angiogenesis is regulated by several growth factors such as VEGF, FGF-2, and ANGPT-1 (Narasimhan et al. 2021). The cardiac gene expression of FGF-2, VEGF, and ANGPT-1 markedly increased in ISP rats compared to NG rats (p < 0.001). Rats treated with Se, PTXF, or Se/PTXF had a more increase in cardiac mRNA expression of FGF-2, VEGF, and ANGPT-1 than the ISP rats (p < 0.001). The Se/PTXF combination was more effective in upregulating the cardiac mRNA expression of FGF-2, VEGF, and ANGPT-1 than monotherapy (p < 0.001) (Table 3). Table 3 Cardiac expression of angiogenesis genes in rats with MI induced by ISP and treated with selenium, pentoxifylline, or their combination

Groups	VEGF/GAPDH	FGF-2/GAPDH	ANGPT-1/GAPDH	
NG	1 ± 0.014	1 ± 0.011	1 ± 0.012	
ISP	1.82 ± 0.08*	1.6 ± 0.08*	1.6 ± 0.13*	
Se	2.7 ± 0.11#	2.4 ± 0.09#	2.8 ± 0.2#	
PTXF	2.4 ± 0.09#	2.3 ± 0.07#	2.4 ± 0.19#	
Se + PTXF	4.12 ± 0.33#ab	3.5 ± 0.13# ab	4.13 ± 0.39# ab	
MI was induced in rats with isoprenaline (ISP). Rats were treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). Results are expressed as mean ± SD, n = 6

*significant difference versus NG group at p < 0.001

#significant difference versus ISP group at p < 0.001

asignificant difference versus Se group at p < 0.001

bsignificant difference versus PTXF group at p < 0.001

Cardiac vascular density

To further confirm the angiogenic effects of Se and PTXF during myocardial healing, heart sections were immunohistochemically stained for CD31, which is a vascular density marker (Liu and Shi 2012). CD31 was detected in the endothelium of regenerating and mature vessels and was significantly increased in the ISP rats, compared to the NG rats (p < 0.001). CD31-positive staining was further increased upon treatment with Se, PTXF, or Se/PTXF (p < 0.001). The Se/PTXF combination was more effective in increasing vascular density than monotherapy (p < 0.001) (Fig. 7).Fig. 7 Cardiac vascular density in rats with MI induced by isoprenaline (ISP) and treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). CD31-stained sections from A NG group, B ISP group, C Se group, D PTXF group, and E Se + PTXF group. Arrow: brown color indicates positive reaction for CD31, a vascular density marker that indicates angiogenesis. (Scale bar 20, × 200). F Vascular density (CD31-positive counts/area). Results are expressed as mean ± SD, n = 6

Cardiac histopathology

Examination of H&E-stained sections from the hearts of NG rats revealed normal architecture with intact striated myofibers and clear intercalated discs. The myofibers showed an acidophilic sarcoplasm and had normal oval nuclei. Neither inflammatory cellular infiltration nor vascular congestion was observed. Myofibers were separated by small amounts of connective tissue that encompassed fibroblasts (Fig. 8A).Fig. 8 Myocardial architecture of heart tissues from rats with MI induced by isoprenaline (ISP) and treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). H&E-stained heart sections from A NG group, B ISP group, C Se group, D PTXF group, and E Se + PTXF group. F Myofiber diameter (µm), quantified using Image J software. Results are expressed as mean ± SD, n = 6. F, myofibers; arrows, normal nuclei; *, transverse striations; arrowhead, intercalated discs; curved arrow, connective tissue containing fibroblasts; oval, inflammatory cellular infiltration; BL, congested blood vessels; double arrows, extravasated blood vessels; H, hyaline appearance; rectangle, pyknotic nuclei; S, spaces between myofibers; thick arrows, darkly stained nuclei (H&E, scale bar 50 µ, × 400)

Isoprenaline-injected rats showed numerous focal areas of disrupted myocardial structure with marked inflammatory cellular infiltration along with blood vessel congestion and extravasation. This was detected in the apical area of the left ventricle, mainly in the innermost area of the subendocardium. Several myofibers were distended and interrupted with vacuolations and extensive separations, while others showed a strongly eosinophilic cytoplasm and a hyaline layout with loss of their typical striations and intercalated discs. Most nuclei were disrupted and darkly stained (Fig. 8B).

Se and PTXF treatment led to significant improvements in myocardial architecture. Only some congestion and mild inflammatory cellular infiltrate were observed. Most myofibers were intact, while others had dark nuclei. Few myofibers showed an intensely acidophilic cytoplasm and a hyaline appearance. The greatest improvements were seen in rats treated with the Se/PTXF combination, where minimal inflammatory cellular infiltration, minimally congested blood vessels, and only some spaces between myofibrils were observed. Most myofibers were intact while few had darkly stained nuclei (Fig. 8C–E).

Myofiber diameter, a sign of cardiac hypertrophy, was significantly increased in ISP-infarcted hearts compared to NG hearts (p < 0.001). Treatment with Se, PTXF, and their combination significantly reduced myofibers diameter compared to ISP-infarcted hearts (p < 0.001). Importantly, the combination of both Se and PTXF caused a more significant reduction in myofiber diameter than individual treatments (p < 0.001) (Fig. 8F).

Cardiac fibrosis

Fibrotic scars and collagen deposition in cardiac muscle frequently happen following MI (Hinderer and Schenke-Layland 2019). Masson’s trichrome-stained heart sections from ISP-treated rats showed a significant increase in cardiac fibrosis, compared to the NG group (p < 0.001). Treatment with Se, PTXF, or Se/PTXF combination significantly decreased cardiac fibrosis compared to the ISP group (p < 0.001) with the best results observed in the Se/PTXF combined group (p < 0.01) (Fig. 9).Fig. 9 Cardiac fibrosis in heart sections from rats with MI induced by isoprenaline (ISP) and treated orally with selenium (Se), pentoxifylline (PTXF), or their combination (Se + PTXF). Masson’s trichrome-stained heart sections from A NG group, B ISP group, C Se group, D PTXF group, and E Se + PTXF group. Arrow, collagen fiber deposition; *, congested blood vessels; arrowhead, extravasated blood. (Masson’ trichrome, scale bar 20 µ, × 200). F Percentage of fibrosis quantified using ImageJ software. Results are expressed as mean ± SD, n = 6

Discussion

Several studies had shown that therapeutic angiogenesis may be an effective strategy for management of ischemic diseases such as MI, particularly for patients who are not eligible for traditional methods of revascularization (Moghiman et al. 2021; Spadaccio et al. 2022; Zhang et al. 2022). This strategy involves restoring perfusion to ischemic regions through stimulation of neovascularization and maturation of preexisting vasculature into functional ones (Moghiman et al. 2021). Our study demonstrated for the first time the cardiac angiogenic effects of Se both alone and in combination with PTXF in rats with ISP-induced MI and that these effects were mediated through Akt/HIF-1α signaling. We showed that Se and PTXF administration increased cardiac vascular density and upregulated angiogenic gene expression. Moreover, we showed for the first time that combining PTXF with Se had more advantageous effects in ameliorating myocardial injury than either monotherapy.

To investigate the potential cardio-therapeutic effects of both Se and PTXF, we induced MI in rats by administering two high doses of ISP. Isoprenaline is a standard model for MI that provides a good understanding of this disease and is commonly used to evaluate the cardioprotective effects of drugs and natural products (Cinar et al. 2022; Pawar et al. 2022; Wahid et al. 2022). Isoprenaline is a synthetic sympathomimetic with nonselective β-adrenoceptor agonist effects. Upon binding to its receptor, it produces positive inotropic and chronotropic effects leading to myocardial hyperfunction. It also reduces coronary blood flow creating an imbalance between oxygen demand and supply and a hypoxic state in the myocardium (Siddiqui et al. 2016; Khalifa et al. 2021).

Besides, ISP generates cytotoxic free radicles and reactive oxygen species (ROS) that result in the peroxidation of membrane lipids (Wong et al. 2017). Moreover, ISP elevates intracellular calcium levels by activating adenylate cyclase, which breaks down ATP and produces cyclic adenosine monophosphate (c-AMP). Collectively, this results in myocardial structural damage and functional deterioration (Garg and Khanna 2014). These pathophysiological changes induced by ISP are comparable to those that occur in patients suffering from MI (Siddiqui et al. 2016).

Increased serum levels of the cardiac injury biomarkers CK-MB, LDH, and troponin-I along with ST-segment elevation in ECG are reliable diagnostic markers of MI (Aydin et al. 2019; Vogel et al. 2019). These biomarkers are present in the heart in a high concentration and are released into the circulation when cardiac damage occurs (Aydin et al. 2019; Sajid et al. 2022). In our study, ISP caused a significant increase in ST-segment elevation and serum levels of CK-MB, LDH, and troponin-I compared to normal rats. These changes in cardiac injury biomarkers could be attributed to lipid peroxidation and myocardial membrane damage induced by ISP and are in accordance with previous studies (Ahmad et al. 2022; Ramakrishna and Krishnamurthy 2022; Sajid et al. 2022).

Treatment with Se and PTXF significantly ameliorated the elevation in ST segment and cardiac injury biomarkers with the best effects observed in the combined therapy group (Table 1). Previous studies reported the ability of Se to improve cardiac injury biomarkers showing its cardioprotective effects against MI induced in rats by ISP and by coronary artery ligation (Al-Rasheed et al. 2013; Dallak 2017). Furthermore, the improvement in cardiac biomarkers following PTXF treatment is in accordance with previous findings reported in arsenic-induced cardiotoxicity in mice and ischemia–reperfusion injury in rats (Matboli et al. 2020; Gholami et al. 2021).

The changes observed in cardiac injury biomarkers were further supported by histopathological examination. In agreement with previous studies, ISP resulted in a disrupted myocardial structure, congested blood vessels, obvious inflammatory cellular infiltration, and increased perivascular and interstitial collagen deposition (Çetin 2019; Kushwah et al. 2022). On the other hand, treatment with Se and PTXF improved myocardial architecture and reduced inflammatory cellular infiltration, congestion and fibrosis. The best improvements in myocardial structure were observed in the Se/PTXF combined group (Figs. 8 and 9). Similar histological findings were reported in MI induced by coronary artery ligation upon treatment with Se and in ischemia/reperfusion injury after treatment with PTXF (Dallak 2017; Matboli et al. 2020).

Oxidative stress is highly associated with MI, where excessive ROS production and depleted antioxidant defenses initiate a cascade of pathological changes that result in cardiomyocyte structural and functional damage (Grieve et al. 2004; Khalifa et al. 2021). Accordingly, ISP-treated rats showed a significant increase in the cardiac levels of MDA, a lipid peroxidation product, along with a marked decrease in the non-enzymatic and enzymatic antioxidant biomarkers: GSH and SOD. On the other hand, treatment with Se or PTXF resulted in a significant increase in antioxidant markers and a significant decrease in cardiac MDA, especially in the Se/PTXF group (Fig. 3).

Previous studies had shown the antioxidant effects of Se in ISP-induced MI in rats and in cadmium-induced cardiotoxicity in rabbits (Al-Rasheed et al. 2013; Feng et al. 2022). Selenium is thought to be one of the cornerstones of the body’s antioxidant defense system (Heyland et al. 2005; Tinggi 2008). It is incorporated into selenoproteins that play several roles in cellular redox regulation. Many of those selenoproteins are crucial for cardiovascular health including glutathione peroxidase and thioredoxin reductase (Mangiapane et al. 2014; Benstoem et al. 2015). Glutathione peroxidase protects cells from DNA and lipoprotein damage through the detoxification of intracellular hydrogen peroxide, while thioredoxin reductase is responsible for thioredoxin regeneration thus maintaining a balanced redox status (Benstoem et al. 2015).

Since pentoxifylline is a phosphodiesterase inhibitor, it increases c-AMP, resulting in reduced superoxide anion generation (Bessler et al. 1986). PTXF was also shown to be an effective scavenger of hydroxyl radicals and provide protection from ROS and associated endothelial injury (Zhang et al. 2004). Our findings are supported by previous studies that reported the antioxidant effects of PTXF in arsenic-induced cardiotoxicity in mice and in doxorubicin-induced cardiac damage in rats (Elshazly et al. 2016; Gholami et al. 2021). Importantly, combining PTXF and Se in our study resulted in more significant improvements in antioxidant markers compared to monotherapy, Fig. 3.

Inflammation is strongly involved in MI pathophysiology (Deten et al. 2002; Debrunner et al. 2008; Prondzinsky et al. 2012). In agreement with previous studies, ISP administration resulted in a significant increase in the cardiac mRNA expression as well as the cardiac protein levels of pro-inflammatory cytokines TNF-α, IL1β, and IL-6, compared to the normal group (Kumar et al. 2016; Khalifa et al. 2021; Cinar et al. 2022). ISP induces inflammation via phospholipase activation and the consequent release of arachidonic acid (Siddiqui et al. 2016; Dhivya et al. 2017). Moreover, ISP results in the activation of NF-κB signaling and consequently the transcription of pro-inflammatory cytokines (Hussain et al. 2016; Kumar et al. 2016).

Treatment with Se and PTXF significantly ameliorated cardiac inflammation as illustrated by a marked decrease in the cardiac mRNA expression as well as the cardiac protein levels of TNF-α, IL1β, and IL-6 (Fig. 4 and Table 2). The anti-inflammatory effects of Se are in agreement with those reported by Dallak et al. in coronary artery ligation–induced MI in rats (Dallak 2017). The anti-inflammatory effect of Se could be attributed to the inhibition of the NF-κB cascade leading to a reduction in TNF-α and interleukin transcription (Benstoem et al. 2015). On the other hand, PTXF exerts its anti-inflammatory effect by inhibiting phosphodiesterase activity, thus increasing c-AMP levels and activating protein kinase A. The latter suppresses NF-κB signaling, resulting in reduced expression of pro-inflammatory cytokines (Zhang et al. 2004). The anti-inflammatory effects of PTXF reported here are in agreement with previous findings reported in doxorubicin-induced cardiac damage in rats (Elshazly et al. 2016; Abbas and Kabil 2017). Combining Se with PTXF ameliorated cardiac inflammation more effectively than individual treatments (Fig. 4 and Table 2).

Apoptosis is a crucial pathological characteristic of MI (Abbate et al. 2005, 2006). Oxidative stress activates intrinsic apoptosis by inhibiting the functions of anti-apoptotic proteins such as Bcl-2 and enhancing those of the pro-apoptotic protein Bax, which eventually leads to the activation of effector caspases such as caspase-3 (Redza-Dutordoir and Averill-Bates 2016; Jeng et al. 2018). Furthermore, inflammation can activate extrinsic apoptosis via the interaction of the pro-inflammatory cytokine TNF-α with its receptors, which leads to the activation of caspase-8 and executioner caspases (Kuwano and Hara 2000; Park et al. 2007). Therefore, the inflammation and oxidative stress induced by ISP could explain the marked increase in the cardiac mRNA expression as well as the cardiac levels of the pro-apoptotic proteins Bax and caspase-3 along with the reduced mRNA expression and levels of the anti-apoptotic protein Bcl-2 (Fig. 5). Our findings are in agreement with previous studies that reported similar apoptotic changes in ISP-treated rats (Saranya et al. 2019; Khalifa et al. 2021).

Treatment with Se and PTXF ameliorated the apoptotic changes induced by ISP, as indicated by the significant decrease in cardiac Bax and caspase-3 mRNA and protein expression levels along with the significant increase in those of Bcl-2 (Fig. 5). The anti-apoptotic effects of Se are in agreement with those previously reported in a rat model of coronary artery ligation-induced MI, while the PTXF anti-apoptotic effects are in agreement with findings previously reported in adriamycin-induced cardiotoxicity in rats (Zang et al. 2015; Dallak 2017). The anti-apoptotic effects of Se and PTXF may be a result of their antioxidant and anti-inflammatory effects. Combining Se with PTXF in our study showed more beneficial effects in ameliorating apoptosis (Fig. 5).

Therapeutic angiogenesis is a novel approach for myocardial healing following ischemia (Wu et al. 2021). It is a complex process that is regulated by several angiogenic factors such as VEGF, FGF-2, and ANGPT-1 (Narasimhan et al. 2021). Thus, targeting the expression of these angiogenic genes is strongly needed. This can be done through their upstream signaling Akt/HIF-1α which is triggered by hypoxia (Zhang et al. 2018). Previous studies have shown that hypoxia increases Akt phosphorylation which consequently increases the expression of HIF-1α (Li et al. 2008; Karar et al. 2012; Zhang et al. 2018). Under hypoxic conditions, HIF-1α stabilizes, translocates into the nucleus, and dimerizes with HIF-1β to form a complex that then binds to the hypoxia responsive element, triggering the transcription of HIF-1α target genes that control angiogenesis such as VEGF and FGF (Weidemann and Johnson 2008).

In our study, the hypoxic state created by ISP resulted in a marked increase in angiogenesis as illustrated by the significant increase in the expression of the angiogenic genes: ANGPT-1, VEGF, and FGF-2 (Table 3). This was also confirmed histologically, where a significant increase in cardiac vascular density was observed in CD31-stained cardiac sections (Fig. 7). The angiogenesis induced by ISP in our study may be mediated by Akt/HIF-1α signaling, since the cardiac levels of p-Akt and HIF-1α were increased (Fig. 6). However, the angiogenesis induced in response to ISP was not enough to abrogate the cardiac damage in which inflammation, oxidative stress, and apoptosis play key roles.

To the best of our knowledge, no previous studies have investigated the cardiac angiogenic effects of Se either alone or in combination with PTXF or explored its effects on Akt/HIF-1α signaling, in a rat model of MI. Our study revealed for the first time that treatment with Se and PTXF further upregulated the cardiac expression of the angiogenic genes: ANGPT-1, VEGF, and FGF-2 (Table 3). Moreover, a marked increase in cardiac vascular density was observed histologically (Fig. 7). The angiogenic effects of Se reported here are in agreement with a previous study that reported increased plasma VEGF levels in diabetic rats, upon treatment with Se (Vural et al. 2017). In addition, the angiogenic effects of PTXF observed in our study are in agreement with Zhou et al. who reported that PTXF ameliorated tubulointerstitial fibrosis via the upregulation of VEGF expression in a rat model of obstructive nephropathy (Zhou et al. 2009).

Interestingly, we showed that treatment with Se induced a marked increase in the cardiac levels of p-Akt and HIF-1α (Fig. 6). Our findings are in agreement with a previous study where Se activated Akt signaling in cadmium-induced cardiac injury in rabbits (Feng et al. 2022). We also showed that PTXF activated Akt signaling, which is in agreement with previous findings reported in a mouse model of testicular torsion-detorsion (Dhulqarnain et al. 2021). Finally, the Se/PTXF combination was more effective in promoting cardiac angiogenesis than monotherapy.

Conclusion

Our study revealed for the first time the cardiac angiogenic effects of Se both alone and in combination with PTXF in MI induced by ISP and that these effects were achieved via the activation of Akt signaling pathway. Furthermore, administration of Se and PTXF resulted in the amelioration of inflammation, oxidative stress, and apoptosis. As a result, Se and/or PTXF treatment improved myocardial structure and function. Most importantly, Se/PTXF combined therapy achieved the best therapeutic outcomes.

Abbreviations

Akt Protein kinase-B

ANGPT Angiopoietin

Bax Bcl-2-associated X

Bcl-2 B cell lymphoma 2

c-AMP Cyclic adenosine monophosphate

CK-MB Creatine kinase-MB

FGF Fibroblast growth factor

GSH Glutathione

HIF-1α Hypoxia inducible factor-1 alpha

HW/TL Heart weight to tibial length ratio

IL-1β Interleukin-1β

IL-6 Interleukin-6

ISP Isoprenaline

LDH Lactate dehydrogenase

LV Left ventricle

MDA Malondialdehyde

MI Myocardial infarction

mTOR Mammalian target of rapamycin

PTXFF Pentoxifylline

ROS Reactive oxygen species

Se Selenium

SOD Superoxide dismutase

TNF-α Tumor necrosis factor-alpha

VEGF Vascular endothelial growth factor

Author contributions

M.M.E: Conceptualization, supervision, writing—original draft, writing—review and editing. S.I.A: Conceptualization, supervision, writing—review and editing. M.A.S: Data curation, formal analysis, investigation, writing review and editing. A.M.A: Investigation, data curation, formal analysis, visualization, writing—original draft. S.K.H: Conceptualization, supervision, visualization, writing—original draft, writing—review and editing. The authors declare that all data were generated in-house and that no paper mill was used.

Funding

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

Data availability

Data are available from the corresponding author upon reasonable request.

Declarations

Ethics approval

Experimental protocol was approved by the Institutional Animal Care and Use Committee, Zagazig University (ZU-IACUC): approval number ZU IACUC/3/F/168/2021. National Institutes of Health (NIH) guidelines for the handling of laboratory animals were followed during the design of experimental protocol and procedures.

Consent for publication

All the authors have approved and agreed to publish this manuscript.

Competing interests

The authors declare no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

Abbas NA Kabil SL Pentoxifylline and cilostazol against rat heart injuries induced by doxorubicin Egypt J Basic Clin Pharmacol 2017 7 47 56
Abbate A Bussani R Biondi-Zoccai GG Santini D Petrolini A Giorgio FD Vasaturo F Scarpa S Severino A Liuzzo G Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium Eur Heart J 2005 26 2039 2045 10.1093/eurheartj/ehi419 16030061
Abbate A Bussani R Amin MS Vetrovec GW Baldi A Acute myocardial infarction and heart failure: role of apoptosis Int J Biochem Cell Biol 2006 38 1834 1840 10.1016/j.biocel.2006.04.010 16781883
Ahmad T Haq IU Khan T Mahnashi MH Alasmary MY Almedhesh SA Shehri HA Alshahrani MA Shah AJ Bergenin from Bergenia species produces a protective response against myocardial infarction in rats Processes 2022 10 1403 10.3390/pr10071403
Ahmed LA Hassan OF Galal O Mansour DF El-Khatib A Beneficial effects of benfotiamine, a NADPH oxidase inhibitor, in isoproterenol-induced myocardial infarction in rats PLoS One 2020 15 e0232413 10.1371/journal.pone.0232413 32384080
Al-Mubarak AA van der Meer P Bomer N Selenium, selenoproteins, and heart failure: current knowledge and future perspective Curr Heart Fail Rep 2021 18 122 131 10.1007/s11897-021-00511-4 33835398
Al-Rasheed NM Attia HA Mohamed RA Al-Rasheed NM Al-Amin MA Preventive effects of selenium yeast, chromium picolinate, zinc sulfate and their combination on oxidative stress, inflammation, impaired angiogenesis and atherogenesis in myocardial infarction in rats JPPS 2013 16 848 867 10.18433/J34C7N 24393559
Aydin S Ugur K Aydin S Sahin İ Yardim M Biomarkers in acute myocardial infarction: current perspectives Vasc Health Risk Manag 2019 15 1 10.2147/VHRM.S166157 30697054
Baraka AM Guemei A Gawad HA Role of modulation of vascular endothelial growth factor and tumor necrosis factor-alpha in gastric ulcer healing in diabetic rats Biochem Pharmacol 2010 79 1634 1639 10.1016/j.bcp.2010.02.001 20144589
Benstoem C Goetzenich A Kraemer S Borosch S Manzanares W Hardy G Stoppe C Selenium and its supplementation in cardiovascular disease—what do we know? Nutrients 2015 7 3094 3118 10.3390/nu7053094 25923656
Bessler H Gilgal R Djaldetti M Zahavi I Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells J Leukoc Biol 1986 40 747 754 10.1002/jlb.40.6.747 3023514
Broeke J, Pérez JMM, Pascau J (2015) Image processing with ImageJ. Packt Publishing Ltd
Çetin E Pretreatment with β-glucan attenuates isoprenaline-induced myocardial injury in rats Exp Physiol 2019 104 505 513 10.1113/EP086739 30677174
Cinar I Yayla M Tavaci T Toktay E Ugan RA Bayram P Halici H In vivo and in vitro cardioprotective effect of Gossypin against isoproterenol-induced myocardial infarction injury Cardiovasc Toxicol 2022 22 52 62 10.1007/s12012-021-09698-3 34599475
Dallak M A synergistic protective effect of selenium and taurine against experimentally induced myocardial infarction in rats Arch Physiol Biochem 2017 123 344 355 10.1080/13813455.2017.1347687 28699791
Debrunner M Schuiki E Minder E Straumann E Naegeli B Mury R Bertel O Frielingsdorf J Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock Clin Res Cardiol 2008 97 298 305 10.1007/s00392-007-0626-5 18491171
Deten A Volz HC Briest W Zimmer H-G Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats Cardiovasc Res 2002 55 329 340 10.1016/S0008-6363(02)00413-3 12123772
Dhivya V Priya LB Chirayil HT Sathiskumar S Huang C-Y Padma VV Piperine modulates isoproterenol induced myocardial ischemia through antioxidant and anti-dyslipidemic effect in male Wistar rats Biomed Pharmacother 2017 87 705 713 10.1016/j.biopha.2017.01.002 28088738
Dhulqarnain AO Takzaree N Hassanzadeh G Tooli H Malekzadeh M Khanmohammadi N Yaghobinejad M Solhjoo S Rastegar T Pentoxifylline improves the survival of spermatogenic cells via oxidative stress suppression and upregulation of PI3K/AKT pathway in mouse model of testicular torsion-detorsion Heliyon 2021 7 e06868 10.1016/j.heliyon.2021.e06868 33997400
Elseweidy M Ali SI Shaheen MA Abdelghafour AM Hammad SK (2023) Vanillin and pentoxifylline ameliorate isoproterenol-induced myocardial injury in rats via Akt/HIF-1α/VEGF signaling pathway Food Funct 2023 14 3067 3082 10.1039/D2FO03570G 36917190
Elshazly SM Mahmoud AAA Barakat W Pentoxifylline abrogates cardiotoxicity induced by the administration of a single high dose or multiple low doses of doxorubicin in rats Can J Physiol Pharmacol 2016 94 1170 1177 10.1139/cjpp-2016-0115 27461572
Feng J Yang F Wu H Xing C Xue H Zhang L Zhang C Hu G Cao H Selenium protects against cadmium-induced cardiac injury by attenuating programmed cell death via PI3K/AKT/PTEN signaling Environ Toxicol 2022 37 1185 1197 10.1002/tox.23475 35099092
Garcia FAdO Rebouças JF Balbino TQ da Silva TG de Carvalho-Júnior CHR Cerqueira GS Brito GAdC Viana GSdB Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase J Inflamm 2015 12 33 10.1186/s12950-015-0080-5
Garg M Khanna D Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models Ther Adv Cardiovasc Dis 2014 8 155 169 10.1177/175394471453 24817146
Ghazouani L Khdhiri E Elmufti A Zarei A Feriani A Baaziz I Hajji R Abid M Ammar H Abid S Allouche N Mnafgui K Ramazani A Tlili N A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N′-(1-(3-oxo-3H-benzo[f]chromen-2-yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes and electrocardiogram Clin Exp Pharmacol Physiol 2022 49 1010 1026 10.1111/1440-1681.13690 35717592
Gholami A Ataei S Ahmadimoghaddam D Omidifar N Nili-Ahmadabadi A Pentoxifylline attenuates arsenic trioxide-induced cardiac oxidative damage in mice Oxid Med Cell Longev 2021 2021 6406318 10.1155/2021/6406318 33505582
Grieve DJ Byrne JA Cave AC Shah AM Role of oxidative stress in cardiac remodelling after myocardial infarction Heart Lung Circ 2004 13 132 138 10.1016/j.hlc.2004.02.008 16352183
Hammad SK Eissa RG Shaheen MA Younis NN Resveratrol ameliorates aortic calcification in ovariectomized rats via SIRT1 signaling CIMB 2021 43 1057 1071 10.3390/cimb43020075 34563044
Heyland DK Dhaliwal R Suchner U Berger MM Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient Intensive Care Med 2005 31 327 337 10.1007/s00134-004-2522-z 15605227
Hinderer S Schenke-Layland K Cardiac fibrosis – a short review of causes and therapeutic strategies Adv Drug Deliv Rev 2019 146 77 82 10.1016/j.addr.2019.05.011 31158407
Hussain T Tan B Yin Y Blachier F Tossou MCB Rahu N Oxidative stress and inflammation: what polyphenols can do for us? Oxid Med Cell Longev 2016 2016 7432797 10.1155/2016/7432797 27738491
Jafarinezhad Z Rafati A Ketabchi F Noorafshan A Karbalay-Doust S Cardioprotective effects of curcumin and carvacrol in doxorubicin-treated rats: stereological study Food Sci Nutr 2019 7 3581 3588 10.1002/fsn3.1210 31763008
Jeng PS Inoue-Yamauchi A Hsieh JJ Cheng EH BH3-dependent and independent activation of BAX and BAK in mitochondrial apoptosis Curr Opin Physiol 2018 3 71 81 10.1016/j.cophys.2018.03.005 30334018
Johnson T Zhao L Manuel G Taylor H Liu D Approaches to therapeutic angiogenesis for ischemic heart disease J Mol Med 2019 97 141 151 10.1007/s00109-018-1729-3 30554258
Karar J Cerniglia GJ Lindsten T Koumenis C Maity A Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia Cancer Biol Ther 2012 13 1102 1111 10.4161/cbt.21144 22895065
Khalifa AA Rashad RM El-Hadidy WF Thymoquinone protects against cardiac mitochondrial DNA loss, oxidative stress, inflammation and apoptosis in isoproterenol-induced myocardial infarction in rats Heliyon 2021 7 e07561 10.1016/j.heliyon.2021.e07561 34355083
Kumar M Kasala ER Bodduluru LN Dahiya V Lahkar M Baicalein protects isoproterenol induced myocardial ischemic injury in male Wistar rats by mitigating oxidative stress and inflammation Inflamm Res 2016 65 613 622 10.1007/s00011-016-0944-z 27071824
Kushwah AS Mittal R Kumar M Kaur G Goel P Sharma RK Kabra A Nainwal LM Cardioprotective activity of Cassia fistula L. bark extract in isoproterenol-induced myocardial infarction rat model Evid Based Complement Altern Med 2022 2022 6874281 10.1155/2022/6874281
Kuwano K Hara N Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family Am J Respir Cell Mol Biol 2000 22 147 149 10.1165/ajrcmb.22.2.f178 10657934
Li L Qu Y Mao M Xiong Y Mu D The involvement of phosphoinositid 3-kinase/Akt pathway in the activation of hypoxia-inducible factor-1α in the developing rat brain after hypoxia–ischemia Brain Res 2008 1197 152 158 10.1016/j.brainres.2007.12.059 18241842
Little R Zi M Hammad SK Nguyen L Njegic A Kurusamy S Prehar S Armesilla AL Neyses L Austin C Cartwright EJ Reduced expression of PMCA1 is associated with increased blood pressure with age which is preceded by remodelling of resistance arteries Aging Cell 2017 16 1104 1113 10.1111/acel.12637 28795531
Liu L Shi G-P CD31: beyond a marker for endothelial cells Cardiovasc Res 2012 94 3 5 10.1093/cvr/cvs108 22379038
Mangiapane E Pessione A Pessione E Selenium and selenoproteins: an overview on different biological systems Curr Protein Pept Sci 2014 15 598 607 10.2174/1389203715666140608151134 24910086
Matboli M Habib EK Hussein Mohamed R Mahran NA Seleem HS Nosseir N Hasanin AH Pentoxifylline alleviated cardiac injury via modulating the cardiac expression of lncRNA-00654-miR-133a-SOX5 mRNA in the rat model of ischemia-reperfusion Biomed Pharmacother 2020 124 109842 10.1016/j.biopha.2020.109842 31972363
Moghiman T Barghchi B Esmaeili S-A Shabestari MM Tabaee SS Momtazi-Borojeni AA Therapeutic angiogenesis with exosomal microRNAs: an effectual approach for the treatment of myocardial ischemia Heart Fail Rev 2021 26 205 213 10.1007/s10741-020-10001-9 32632768
Mohamed HE, Askar ME, Shaheen MA, Salama AE, Idris RA, Younis NN (2023) Infliximab substantially re-silenced Wnt/β-catenin signaling and ameliorated doxorubicin-induced cardiomyopathy in rats. J Biochem Mol Toxicol e23312. 10.1002/jbt.23312
Narasimhan B Narasimhan H Lorente-Ros M Romeo FJ Bhatia K Aronow WS Therapeutic angiogenesis in coronary artery disease: a review of mechanisms and current approaches Expert Opin Investig Drugs 2021 30 947 963 10.1080/13543784.2021.1964471 34346802
Nowbar AN Gitto M Howard JP Francis DP Al-Lamee R Mortality from ischemic heart disease Circ Cardiovasc Qual Outcomes 2019 12 e005375 10.1161/CIRCOUTCOMES.118.005375 31163980
Park HH, Lo Y-C, Lin S-C, Wang L, Yang JK, Wu H (2007) The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol 25. 10.1146/annurev.immunol.25.022106.141656
Pawar HD Mahajan UB Nakhate KT Agrawal YO Patil CR Meeran M Sharma C Ojha S Goyal SN Curcumin protects diabetic mice against isoproterenol-induced myocardial infarction by modulating CB2 cannabinoid receptors Life 2022 12 624 10.3390/life12050624 35629293
Prondzinsky R Unverzagt S Lemm H Wegener N Heinroth K Buerke U Fiedler M Thiery J Haerting J Werdan K Acute myocardial infarction and cardiogenic shock Med Klin Intensivmed Notfmed 2012 107 476 484 10.1007/s00063-012-0117-y 22810435
Ramakrishna K Krishnamurthy S Indole-3-carbinol ameliorated the isoproterenol-induce myocardial infarction via multimodal mechanisms in Wistar rats Nat Prod Res 2022 36 23 6044 6049 10.1080/14786419.2022.2041632 35175868
Redza-Dutordoir M Averill-Bates DA Activation of apoptosis signalling pathways by reactive oxygen species Biochim Biophys Acta Mol Cell Res 2016 1863 2977 2992 10.1016/j.bbamcr.2016.09.012
Sajid A Ahmad T Ikram M Khan T Shah AJ Mahnashi MH Alhasaniah AH Al Awadh AA Almazni IA Alshahrani MM Cardioprotective potential of aqueous extract of Fumaria indica on isoproterenol-induced myocardial infarction in SD rats Oxid Med Cell Longev 2022 2022 2112956 10.1155/2022/2112956 35757502
Saranya S Baskaran R Poornima P Vijaya Padma V Berbamine ameliorates isoproterenol-induced myocardial infarction by inhibiting mitochondrial dysfunction and apoptosis in rats J Cell Biochem 2019 120 3101 3113 10.1002/jcb.27522 30485494
Shalihat A Hasanah AN Mutakin LR Budiman A Gozali D The role of selenium in cell survival and its correlation with protective effects against cardiovascular disease: a literature review Biomed Pharmacother 2021 134 111125 10.1016/j.biopha.2020.111125 33341057
Siddiqui M Ahmad U Khan A Ahmad M Badruddeen KM Akhtar J Isoprenaline: a tool for inducing myocardial infarction in experimental animals Int J Pharm 2016 6 138 144
Spadaccio C Nenna A Rose D Piccirillo F Nusca A Grigioni F Chello M Vlahakes GJ The role of angiogenesis and arteriogenesis in myocardial infarction and coronary revascularization J Cardiovasc Trans Res 2022 15 1024 1048 10.1007/s12265-022-10241-0
Suvarna KS, Layton C, Bancroft JD (2018) Bancroft’s theory and practice of histological techniques E-Book. Elsevier health sciences
Tapiero H Townsend DM Tew KD The antioxidant role of selenium and seleno-compounds Biomed Pharmacother 2003 57 134 144 10.1016/S0753-3322(03)00035-0 12818475
Tinggi U Selenium: its role as antioxidant in human health Environ Health Prev Med 2008 13 102 108 10.1007/s12199-007-0019-4 19568888
Tomanek RJ Schatteman GC Angiogenesis: new insights and therapeutic potential Anat Rec 2000 261 126 135 10.1002/1097-0185(20000615)261:3<126::AID-AR7>3.0.CO;2-4 10867630
Vogel B Claessen BE Arnold SV Chan D Cohen DJ Giannitsis E Gibson CM Goto S Katus HA Kerneis M ST-segment elevation myocardial infarction Nat Rev Dis Prim 2019 5 1 20 10.1038/s41572-019-0090-3 30617281
Vural P, Kabaca G, Firat RD, Degirmecioglu S (2017) Administration of selenium decreases lipid peroxidation and increases vascular endothelial growth factor in streptozotocin induced diabetes mellitus. Cell J (Yakhteh) 19: 452. 10.22074/CELLJ.2017.4161
Wahid M Saqib F Chicea L Ahmedah HT Sajer BH Marc RA Pop OL Moga M Gavris C Metabolomics analysis delineates the therapeutic effects of hydroethanolic extract of Cucumis sativus L. seeds on hypertension and isoproterenol-induced myocardial infarction Biomed Pharmacother 2022 148 112704 10.1016/j.biopha.2022.112704 35180666
Weidemann A Johnson RS Biology of HIF-1α Cell Death Differ 2008 15 621 627 10.1038/cdd.2008.12 18259201
Wen WX Lee SY Siang R Koh RY Repurposing pentoxifylline for the treatment of fibrosis: an overview Adv Ther 2017 34 1245 1269 10.1007/s12325-017-0547-2 28484954
Wong ZW Thanikachalam PV Ramamurthy S Molecular understanding of the protective role of natural products on isoproterenol-induced myocardial infarction: a review Biomed Pharmacother 2017 94 1145 1166 10.1016/j.biopha.2017.08.009 28826162
Wu X Reboll MR Korf-Klingebiel M Wollert KC Angiogenesis after acute myocardial infarction Cardiovasc Res 2021 117 1257 1273 10.1093/cvr/cvaa287 33063086
Yan J Liang J Cao Y El Akkawi MM Liao X Chen X Li C Li K Xie G Liu H Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds Stem Cell Res Ther 2021 12 220 10.1186/s13287-021-02288-8 33789742
Younis NN Mohamed HE Shaheen MA Abdelghafour AM Hammad SK Inactivation of Wnt/β-catenin/renin angiotensin axis by tumor necrosis factor-alpha inhibitor, infliximab, ameliorates CKD induced in rats Biochem Pharmacol 2021 185 114426 10.1016/j.bcp.2021.114426 33482150
Younis NN Mohamed HE Shaheen MA Abdelghafour AM Hammad SK Potential therapeutic efficacy of pachymic acid in chronic kidney disease induced in rats: role of Wnt/β-catenin/renin–angiotensin axis J Pharm Pharmacol 2021 74 112 123 10.1093/jpp/rgab129
Younis NN Salama A Shaheen MA Eissa RG Pachymic acid attenuated doxorubicin-induced heart failure by suppressing miR-24 and preserving cardiac junctophilin-2 in rats Int J Mol Sci 2021 22 10710 10.3390/ijms221910710 34639051
Youssef ME El-Mas MM Abdelrazek HM El-Azab MF α7-nAChRs-mediated therapeutic angiogenesis accounts for the advantageous effect of low nicotine doses against myocardial infarction in rats Eur J Pharmacol 2021 898 173996 10.1016/j.ejphar.2021.173996 33684450
Zang Z Li S Lin Y Li X Li Y Qin Y Wang H Jiang M Zhu L Pentoxifylline prevents driamycin-induced myocardial fibrosis and apoptosis in rats Int Heart J 2015 56 651 655 10.1536/ihj.15-203 26549291
Zhang M Xu Y-J Mengi SA Arneja AS Dhalla NS Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases Exp Clin Cardiol 2004 9 103 111 19641695
Zhang Z Yao L Yang J Wang Z Du G PI3K/Akt and HIF-1 signaling pathway in hypoxia-ischemia Mol Med Rep 2018 18 3547 3554 10.3892/mmr.2018.9375 30106145
Zhang M-x Song Y Xu W-l Zhang L-x Li C Li Y-l Natural herbal medicine as a treatment strategy for myocardial infarction through the regulation of angiogenesis Evid Based Complement Altern Med 2022 2022 8831750 10.1155/2022/8831750
Zhou Q-g Zheng F-l Hou F-f Inhibition of tubulointerstitial fibrosis by pentoxifylline is associated with improvement of vascular endothelial growth factor expression Acta Pharmacol Sin 2009 30 98 106 10.1038/aps.2008.11 19079293
